A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

Abstract Background Oxaliplatin is a platinum derivative that has shown efficacy in advanced hepatocellular carcinoma. S-1 is an oral fluoropyrimidine that has substituted for 5-fluorouracil in many cancers. This was a multicenter, open-label, single-arm phase II trial that evaluated the efficacy of...

Full description

Bibliographic Details
Main Authors: Dae-Won Lee, Kyung-Hun Lee, Hee-Jun Kim, Tae-Yong Kim, Jin-Soo Kim, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Seock-Ah Im, Tae-You Kim
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Chemotherapy
Phase II
Oxaliplatin
S-1
Online Access:http://link.springer.com/article/10.1186/s12885-018-4039-9

Internet

http://link.springer.com/article/10.1186/s12885-018-4039-9

Similar Items